Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Erin F. Barreto, Pharm.D., R.Ph., is a clinical pharmacist and researcher who specializes in critical care. Her interests lie in understanding and exploring mechanisms to individualize pharmacotherapy for acutely ill patients. In particular, her research focuses on optimizing the safe and effective use of renally eliminated and nephrotoxic medications. Advances in the understanding of the pathophysiology and outcomes of acute kidney injury (AKI) and novel methods to better detect and quantify kidney dysfunction allow her to continually address new questions about the use of medications in these settings.
Dr. Barreto's research addresses questions that emerge directly from her experiences as a clinical pharmacist and member of the multidisciplinary intensive care unit team. On a daily basis, she works to navigate the safe and effective use of necessary medications processed by, or toxic to, the kidney. Her research agenda addresses this knowledge gap and builds toward the overall goal of improving medication effectiveness and safety in patients at risk of or with kidney dysfunction.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.